Novel transcript, antisense to SALL1 (None established; ENSG00000261238 is the Ensembl gene identifier)

ENSG00000261238 is annotated as a novel long non-coding RNA transcript antisense to SALL1. Antisense transcripts like this are widespread in the genome and may influence the expression of overlapping or neighboring genes by several mechanisms, including transcriptional interference (stalling RNA polymerase during convergent transcription), RNA masking (modulating splicing or stability), double-stranded RNA-dependent processes (such as siRNA generation), or epigenetic chromatin modifications. The functional significance of this particular antisense transcript is not established in literature and it is not classified as a therapeutic target. SALL1 itself encodes a transcription factor critical for microglia identity and organogenesis, but the antisense transcript’s functional or clinical significance remains undefined. This target is not recognized as a conventional therapeutic or biomarker target and is not associated with any approved or investigational drugs. Its main interest lies in gene regulation research and transcriptomics.

General antisense transcript mechanisms may include RNA-RNA duplex formation, modulation of SALL1 mRNA stability, formation of heterochromatin, or regulation of splicing